Bio

Alain Decombe has advised on numerous strategic M&A transactions and advises on all types of corporate transactions, both in France and internationally. He is well-known for his ability to structure and negotiate complex deals in a practical and business-oriented manner, and lead them to successful conclusions. Mr. Decombe regularly advises multinational corporations and private equity funds with respect to their investments in many industry sectors, mostly life sciences, but also food, industrial gases and highly engineered products. Alain Decombe is ranked as a "leading individual" by The Legal 500 EMEA 2024 and Band 1 by Chambers Europe 2024 for life sciences in France with a client saying "Alain is important in the pharma ecosystem in France." In addition, he is recognized as “global leader” and “national leader” by Who’s Who Legal 2022 for life sciences in France and by Best Lawyers in France 2025 in biotechnology, life sciences and corporate law. IFLR1000 2023 recommends Mr. Decombe in its M&A and private equity categories. Mr. Decombe joined Dechert in 2005. He began his career in British and American global law firms. He became a partner of one of those firms in 1995 and took on managing functions for the first time in 2002.